NCT01682083 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 438
- group Id
- BG001
- value
- 432
- group Id
- BG002
- value
- 870
- units
- Participants
- groups
- description
- Subjects received dabrafenib (150 mg twice daily) and trametinib (2 mg once daily) orally for 12 months.
- id
- BG000
- title
- Dabrafenib and Trametinib Combination Therapy
- description
- Subjects received matching placebos orally for 12 months
- id
- BG001
- title
- Dabrafenib and Trametinib Placebos
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 14.17
- value
- 50.4
- group Id
- BG001
- spread
- 13.14
- value
- 50.5
- group Id
- BG002
- spread
- 13.66
- value
- 50.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 195
- group Id
- BG001
- value
- 193
- group Id
- BG002
- value
- 388
- title
- Female
- measurements
- group Id
- BG000
- value
- 243
- group Id
- BG001
- value
- 239
- group Id
- BG002
- value
- 482
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 432
- group Id
- BG001
- value
- 427
- group Id
- BG002
- value
- 859
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 11
- title
- Asian
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 438
- group Id
- BG001
- value
- 432
- group Id
- BG002
- value
- 870
- units
- Participants
- groups
- description
- Subjects received dabrafenib (150 mg twice daily) and trametinib (2 mg once daily) orally for 12 months.
- id
- BG000
- title
- Dabrafenib and Trametinib Combination Therapy
- description
- Subjects received matching placebos orally for 12 months
- id
- BG001
- title
- Dabrafenib and Trametinib Placebos
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- spread
- 14.17
- value
- 50.4
- group Id
- BG001
- spread
- 13.14
- value
- 50.5
- group Id
- BG002
- spread
- 13.66
- value
- 50.4
- dispersion Type
- STANDARD_DEVIATION
- param Type
- MEAN
- title
- Age, Continuous
- unit Of Measure
- Years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 195
- group Id
- BG001
- value
- 193
- group Id
- BG002
- value
- 388
- title
- Female
- measurements
- group Id
- BG000
- value
- 243
- group Id
- BG001
- value
- 239
- group Id
- BG002
- value
- 482
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 432
- group Id
- BG001
- value
- 427
- group Id
- BG002
- value
- 859
- title
- White
- categories
- measurements
- group Id
- BG000
- value
- 6
- group Id
- BG001
- value
- 5
- group Id
- BG002
- value
- 11
- title
- Asian
- param Type
- NUMBER
- title
- Race/Ethnicity, Customized
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle